Clinical Trials Browser

Phase 3 × Completed × Docosahexaenoic Acids × Clear all

NCT00243867 2025-08-01

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Phase 3 Completed

518 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00146211 2007-12-27

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Phase 3 Completed

Huntington Disease, Lymphoma, Follicular